Xin Wei Wang
Auto-generated profile, based on publicly available information

Xin Wei Wang

Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2018 in Science
Verified
Journal Article
Closed access
PDF file
CMChi Ma
Chi Ma
MHMiaojun Han
Miaojun Han
BHBernd Heinrich
Bernd Heinrich
QFQiong Fu
Qiong Fu
QZQianfei Zhang
Qianfei Zhang
TGTim F. Greten
Tim F. Greten
Bile acids and liver cancer: Liver cancer is a leading cause of cancer-related deaths in the United States. The composition of the gut microbiome influences many human diseases, including liver inflammatory disorders. Ma et al. found that commensal gut bacteria can recruit the immune system to control the growth of liver tumors in mice (see the Perspective by Hartmann and Kronenberg). Clostridium species modified bile acids to signal liver sinusoidal endothelial cells to produce the chemokine CXCL16. This recruited natural killer T (NKT) immune cells to perform antitumor surveillance of the liver. Growth of both primary and metastatic cancer was reduced by NKT cell–driven killing. Science , this issue p. eaan5931 ; see also p. 858

1 March 2009 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
TYTaro Yamashita
Taro Yamashita
JJJunfang Ji
Junfang Ji
ABAnuradha Budhu
Anuradha Budhu
MFMarshonna Forgues
Marshonna Forgues
WYWen Yang
Wen Yang
XWXin Wei Wang
Xin Wei Wang

14 December 2010 in Cancer Research
Verified
Journal Article
Open access
PDF file
SRStephanie Roessler
Stephanie Roessler
HJHu-Liang Jia
Hu-Liang Jia
ABAnuradha Budhu
Anuradha Budhu
MFMarshonna Forgues
Marshonna Forgues
QYQing-Hai Ye
Qing-Hai Ye
XWXin Wei Wang
Xin Wei Wang
Metastasis-related recurrence often occurs in hepatocellular carcinoma (HCC) patients who receive curative therapies. At present, it is challenging to identify patients with high risk of recurrence, which would warrant additional therapies. In this study, we sought to analyze a recently developed metastasis-related gene signature for its utility in predicting HCC survival, using 2 independent cohorts consisting of a total of 386 patients who received radical resection. Cohort 1 contained 247 predominantly HBV-positive cases analyzed with an Affymetrix platform, whereas cohort 2 contained 139 cases with mixed etiology analyzed with the NCI Oligo Set microarray platform. We employed a survival risk prediction algorithm with training, test, and independent cross-validation strategies and found that the gene signature is predictive of overall and disease-free survival. Importantly, risk was significantly predicted independently of clinical characteristics and microarray platform. In addition, survival prediction was successful in patients with early disease, such as small (<5 cm in diameter) and solitary tumors, and the signature predicted particularly well for early recurrence risk (<2 years), especially when combined with serum alpha fetoprotein or tumor staging. In conclusion, we have shown in 2 independent cohorts with mixed etiologies and ethnicity that the metastasis gene signature is a useful tool to predict HCC outcome, suggesting the general utility of this classifier. We recommend the use of this classifier as a molecular diagnostic test to assess the risk that an HCC patient will develop tumor relapse within 2 years after surgical resection, particularly for those with early-stage tumors and solitary presentation. Cancer Res; 70(24); 10202–12. ©2010 AACR.

1 October 2019 in Cancer Cell
Verified
Journal Article
Open access
LMLichun Ma
Lichun Ma
MHMaria O. Hernandez
Maria O. Hernandez
YZYongmei Zhao
Yongmei Zhao
MMMonika Mehta
Monika Mehta
BTBao Tran
Bao Tran
XWXin Wei Wang
Xin Wei Wang
Cellular diversity in tumors is a key factor for therapeutic failures and lethal outcomes of solid malignancies. Here, we determined the single-cell transcriptomic landscape of liver cancer biospecimens from 19 patients. We found varying degrees of heterogeneity in malignant cells within and between tumors and diverse landscapes of tumor microenvironment (TME). Strikingly, tumors with higher transcriptomic diversity were associated with patient's worse overall survival. We found a link between hypoxia-dependent vascular endothelial growth factor expression in tumor diversity and TME polarization. Moreover, T cells from higher heterogeneous tumors showed lower cytolytic activities. Consistent results were found using bulk genomic and transcriptomic profiles of 765 liver tumors. Our results offer insight into the diverse ecosystem of liver cancer and its impact on patient prognosis.

1 August 2006 in Cancer Cell
Verified
Journal Article
Closed access
ABAnuradha Budhu
Anuradha Budhu
MFMarshonna Forgues
Marshonna Forgues
QYQing-Hai Ye
Qing-Hai Ye
HJHu-Liang Jia
Hu-Liang Jia
PHPing He
Ping He
XWXin Wei Wang
Xin Wei Wang

17 March 2003 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
QYQing-Hai Ye
Qing-Hai Ye
LQLun-Xiu Qin
Lun-Xiu Qin
MFMarshonna Forgues
Marshonna Forgues
PHPing He
Ping He
JKJin Woo Kim
Jin Woo Kim
XWXin Wei Wang
Xin Wei Wang